Arnold Lee MD

As the leading global authority on the evolution of digital health technology, Digital Therapeutics Alliance (DTA) is a 501(c)(6) non-profit trade association of industry leaders and stakeholders dedicated to the understanding, adoption, and integration of digital therapeutics into healthcare. DTA works to enable expanded access to high quality, evidence-based digital therapeutics for patients, clinicians, and payors to improve clinical and health economic outcomes. As the leading international organization on digital therapeutic thought leadership and education, DTA provides the digital health ecosystem with the necessary tools to define, evaluate, and utilize DTx products. For more information, please visit: www.dtxalliance.org.

We invest in early-stage consumer marketplaces and digital health startups in North America and China. We back visionary entrepreneurs with innovative solutions to improve quality of life. Being sector-focused enables us to support our portfolio companies within an ecosystem. By utilizing unique market insights and a global network, we help early-stage startups to define and refine go-to-market strategies, acquire customers, create suited operating models, fundraise, and more.

CAHP Health is a dedicated pre-seed fund focused on backing exceptional teams in the digital healthcare arena. We are focused on solutions leveraging technology to address true unmet needs in healthcare, with a patient safety focus at the core. We believe the most impactful innovations are those that offer compelling value across multiple stakeholders while meaningfully bending the cost curve of care.

As the leading global authority on the evolution of digital health technology, Digital Therapeutics Alliance (DTA) is a 501(c)(6) non-profit trade association of industry leaders and stakeholders dedicated to the understanding, adoption, and integration of digital therapeutics into healthcare. DTA works to enable expanded access to high quality, evidence-based digital therapeutics for patients, clinicians, and payors to improve clinical and health economic outcomes. As the leading international organization on digital therapeutic thought leadership and education, DTA provides the digital health ecosystem with the necessary tools to define, evaluate, and utilize DTx products. For more information, please visit: www.dtxalliance.org.

Sugati Ventures is an early stage VC Fund focused on Medical Devices and Health Tech platforms. We invest in early stage (Seed and Series A) companies that are working on products and solutions to resolve significant unmet needs in healthcare.

At DigiTx Partners, we believe that the pace of change in healthcare will only accelerate in the coming years. We believe that there are many smart people with great insights and drive who are developing innovative technologies and solutions. We look forward to supporting innovative companies that will make a difference in our healthcare ecosystem, from companies that will change how patients navigate the healthcare system, that will integrate the disparate elements that comprise both diagnosis and treatment, that will speed the development of more effective drugs and that will enhance and enable efficient and accurate physician-patient interaction. DigiTx Partners looks forward to investing in those digital health companies that strive to keep all of us in better health.

We invest in early-stage consumer marketplaces and digital health startups in North America and China. We back visionary entrepreneurs with innovative solutions to improve quality of life. Being sector-focused enables us to support our portfolio companies within an ecosystem. By utilizing unique market insights and a global network, we help early-stage startups to define and refine go-to-market strategies, acquire customers, create suited operating models, fundraise, and more.

CAHP Health is a dedicated pre-seed fund focused on backing exceptional teams in the digital healthcare arena. We are focused on solutions leveraging technology to address true unmet needs in healthcare, with a patient safety focus at the core. We believe the most impactful innovations are those that offer compelling value across multiple stakeholders while meaningfully bending the cost curve of care.